TABLE OF CONTENTS
December 20, 1999
Volume 77, Number 51
CENEAR 77 51 p. 1
ISSN 0009-2347

NEWS OF THE WEEK

Y2K, THE MOLECULE:   5
Concerns about advent of Jan. 1, 2000, are chemically unsubstantiated.

ROCHE LOSES PATENT CASE: 5
Judge rules natural Taq DNA polymerase patent is fraudulent.

HAZARDOUS WASTE: 6
Liability and compensation scheme added to international transport treaty.

CHEMICAL SAFETY BOARD: 6
Truce declared in long-running feud between chairman, members.

OPIOID ANTAGONIST: 7
Small molecule blocks action of receptor linked to locomotion, learning, anxiety.

MONSANTO SUED:   7
Class-action lawsuit charges company instigated global cartel in genetically modified seeds.

DEXTER TAKEOVER TARGET:   8
ISP's Heyman offers $900 million for specialty materials company.

BUSINESS

BUSINESS CONCENTRATES:  9

CAPITAL SPENDING: 11
Group of 17 major chemical producers plan aggregate 5 increase for 2000, but aggressive DuPont skews that figure.

SNPE IN THE U.S.: 13
French firm takes steps to be a major player in U.S. fine chemicals.

RESINS FOR DVDs: 14
New discs may require properties beyond those of workhorse polycarbonate.

ENTREPRENEURS: 16
Paralec's founder built a better electronic circuit board.

GOVERNMENT & POLICY

GOVERNMENT CONCENTRATES:  18

WORLD TRADE TIMEOUT: 19
Talks in Seattle went nowhere, but work on a new agenda continues.

JUSTICE DEPARTMENT: 22
Newly appointed science adviser will support and facilitate policy decisions.

SCIENCE AT STATE: 23
Department sets priorities for environment, science, and technology bureau.

SCIENCE/TECHNOLOGY

SCIENCE/TECHNOLOGY CONCENTRATES:  24

ASTROBIOLOGY: 25
NASA advances its ambitious endeavor to understand how life arose and continues to evolve on Earth.

FASTEST SUPERCOMPUTER: 35
Protein folding will be first challenge for IBM's "Blue Gene."

BOOKS

TOMORROW'S MEDICINES: 37
How scientific curiosity, ambition, and opportunity combine to remake the science and business of medicine.

COVER STORY

NATIONAL CHEMISTRY WEEK: 40
Local sections, student affiliates take science into the community.

ACS NEWS

CHEMICAL LANDMARK: 48
Penicillin is recognized as launching a revolution in disease treatment.

MINORITY AFFAIRS: 50
Panel discusses how ACS can work more closely with advocacy groups.

THE DEPARTMENTS

LETTERS

EDITOR'S PAGE

36 SOFTWARE/ONLINE BRIEFS

51 PEOPLE

52 AWARDS

64 NEWSCRIPTS


Chemical & Engineering News
Copyright © 1999 American Chemical Society